Amgen (AMGN) Assets Average (2009 - 2026)

Amgen's Assets Average history runs 17 years deep, the most recent figure standing at $91.5 billion for Q1 2026.

• In Q1 2026, Assets Average rose 1.04% year-over-year to $91.5 billion; the TTM figure through Mar 2026 stood at $91.5 billion (up 1.04% YoY), while the FY2025 annual figure was $91.2 billion, down 3.48% from the prior year.
• Assets Average was $91.5 billion for Q1 2026 at Amgen, up from $90.4 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $95.1 billion in Q1 2024 to a low of $59.2 billion in Q2 2022.
• Historically, Assets Average has averaged $83.3 billion across 5 years, with a median of $90.4 billion in 2025.
• The sharpest annual moves came in 2023 and 2025: Assets Average surged 51.06% in 2023, then retreated 4.7% in 2025.
• A 5-year view of Assets Average shows it stood at $64.4 billion in 2022, then jumped by 45.7% to $93.8 billion in 2023, then fell by 2.65% to $91.4 billion in 2024, then decreased by 1.09% to $90.4 billion in 2025, then increased by 1.31% to $91.5 billion in 2026.
• The last three Assets Average figures came in at $91.5 billion (Q1 2026), $90.4 billion (Q4 2025), and $89.0 billion (Q3 2025), per Business Quant data.